Xiong S, Liu S, Zhang W, Zeng C, Liao D, Tang T
Diagn Pathol. 2025; 20(1):22.
PMID: 39985045
PMC: 11846261.
DOI: 10.1186/s13000-025-01618-1.
Zhang C, Chi W, Yu X, Wang X, Yang Y, Meng F
Medicine (Baltimore). 2025; 103(52):e41131.
PMID: 39969321
PMC: 11688103.
DOI: 10.1097/MD.0000000000041131.
Zhang K, Wang X, Lei J, Su A, Wei T, Li Z
Ann Surg Oncol. 2025; 32(4):2732-2742.
PMID: 39871079
PMC: 11882711.
DOI: 10.1245/s10434-024-16852-y.
Ouyang G, Zhu Y, Ouyang Z
Sci Rep. 2025; 15(1):2490.
PMID: 39833432
PMC: 11747344.
DOI: 10.1038/s41598-025-86733-1.
Ma Y, Zhou W, Qian Y, Mu Y, Zhang W
Front Immunol. 2024; 15:1478395.
PMID: 39726600
PMC: 11670200.
DOI: 10.3389/fimmu.2024.1478395.
Physicians' preferencesfor radioiodine treatment of differentiated thyroid cancer in Brazil: an observational study.
Padovani R, Pansani I, Marone M, Vaisman F, Maia A, Dora J
Arch Endocrinol Metab. 2024; 68:e230228.
PMID: 39420903
PMC: 11196101.
DOI: 10.20945/2359-4292-2023-0228.
Metastatic Medullary Thyroid Carcinoma Presenting as an Incidental Posterior Mediastinal Mass.
Goldberg C, Diaz D, Brandler T
Cytopathology. 2024; 36(1):71-74.
PMID: 39334533
PMC: 11632166.
DOI: 10.1111/cyt.13449.
Emerging insights into thyroid cancer from immunotherapy perspective: A bibliometric analysis.
Wang Q, Pan G, Zhang Y, Ni Y, Mu Y, Luo D
Hum Vaccin Immunother. 2024; 20(1):2403170.
PMID: 39294892
PMC: 11657091.
DOI: 10.1080/21645515.2024.2403170.
A novel minimally invasive endoscopic approach of thyroid surgery-endoscopic thyroidectomy via sternocleidomastoid muscle posteroinferior approach.
Zhou J, Jing Y, Qi X, Wu J, Huang J, Chen X
Gland Surg. 2024; 13(6):942-951.
PMID: 39015696
PMC: 11247576.
DOI: 10.21037/gs-24-48.
Medullary Thyroid Cancer: Epidemiology and Characteristics According to Data From the Marne-Ardennes Register 1975-2018.
Caille S, Debreuve-Theresette A, Vitellius G, Deguelte S, La Manna L, Zalzali M
J Endocr Soc. 2024; 8(6):bvae084.
PMID: 38745826
PMC: 11091837.
DOI: 10.1210/jendso/bvae084.
Research progress of immunotherapy against anaplastic thyroid cancer.
Chen J, Xiao Z, Wu H
Front Oncol. 2024; 14:1365055.
PMID: 38595813
PMC: 11002090.
DOI: 10.3389/fonc.2024.1365055.
Establishing a Cutoff Serum Thyroglobulin Value for the Diagnosis and Management of Well-Differentiated Thyroid Cancer.
Paudel J
World J Nucl Med. 2023; 22(3):208-216.
PMID: 37854090
PMC: 10581758.
DOI: 10.1055/s-0043-1771286.
Anlotinib combined with Sintilimab is win-win cooperation for primary squamous cell carcinoma of the thyroid: A case report and literature review.
Liu Z, Yu M, Zhao F, Zhu C
Front Oncol. 2023; 13:976415.
PMID: 37007162
PMC: 10062477.
DOI: 10.3389/fonc.2023.976415.
ERCC2 rs13181 Polymorphism Association with Glioma Risk: an Update Meta-Analysis.
Salari N, Rasoulpoor S, Shabani S, Mansouri K, Bokaee S, Fatahian R
Indian J Surg Oncol. 2023; 14(1):60-68.
PMID: 36891435
PMC: 9986186.
DOI: 10.1007/s13193-022-01623-6.
The Role of F-FDOPA PET/CT in Recurrent Medullary Thyroid Cancer Patients with Elevated Serum Calcitonin Levels.
Araz M, Soydal C, Demir O, Gokcan M, Kucuk N
Mol Imaging Radionucl Ther. 2023; 32(1):1-7.
PMID: 36815513
PMC: 9950688.
DOI: 10.4274/mirt.galenos.2022.81904.
Combined fine-needle aspiration and selective intraoperative frozen section to optimize prediction of malignant thyroid nodules: A retrospective cohort study of more than 3000 patients.
Mao Z, Ding Y, Wen L, Zhang Y, Wu G, You Q
Front Endocrinol (Lausanne). 2023; 14:1091200.
PMID: 36814578
PMC: 9939476.
DOI: 10.3389/fendo.2023.1091200.
Cancer overdiagnosis: a challenge in the era of screening.
Dunn B, Woloshin S, Xie H, Kramer B
J Natl Cancer Cent. 2022; 2(4):235-242.
PMID: 36568283
PMC: 9784987.
DOI: 10.1016/j.jncc.2022.08.005.
Deep learning for the diagnosis of suspicious thyroid nodules based on multimodal ultrasound images.
Tao Y, Yu Y, Wu T, Xu X, Dai Q, Kong H
Front Oncol. 2022; 12:1012724.
PMID: 36425556
PMC: 9680169.
DOI: 10.3389/fonc.2022.1012724.
Thyroid cancer in women of reproductive age: Key issues for the clinical team.
Toro-Wills M, Imitola-Madero A, Alvarez-Londono A, Hernandez-Blanquisett A, Martinez-Avila M
Womens Health (Lond). 2022; 18:17455057221136392.
PMID: 36373610
PMC: 9666833.
DOI: 10.1177/17455057221136392.
Analgesic efficacy and safety of nalbuphine versus morphine for perioperative tumor ablation: a randomized, controlled, multicenter trial.
Xue Y, Huang Z, Cheng B, Sun J, Zhu H, Tang Y
Trials. 2022; 23(1):887.
PMID: 36273202
PMC: 9587534.
DOI: 10.1186/s13063-022-06825-5.
